Medicover AB (publ) (LON:0RPS)
214.00
+1.50 (0.71%)
At close: Apr 24, 2025
Medicover AB Revenue
In the year 2024, Medicover AB had annual revenue of 2.09B EUR with 19.78% growth. Medicover AB had revenue of 555.80M in the quarter ending December 31, 2024, with 20.33% growth.
Revenue
2.09B EUR
Revenue Growth
+19.78%
P/S Ratio
1.44
Revenue / Employee
44.27K EUR
Employees
47,256
Market Cap
2.50B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.09B | 345.40M | 19.78% |
Dec 31, 2023 | 1.75B | 236.20M | 15.64% |
Dec 31, 2022 | 1.51B | 132.80M | 9.64% |
Dec 31, 2021 | 1.38B | 379.60M | 38.04% |
Dec 31, 2020 | 997.80M | 153.40M | 18.17% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 43.19B |
GSK plc | 31.38B |
Haleon | 11.23B |
Smith & Nephew | 4.64B |
ConvaTec Group | 1.83B |
Hikma Pharmaceuticals | 2.50B |
HUTCHMED (China) | 503.39M |
Oxford Nanopore Technologies | 183.19M |